Use in Pregnancy: Pregnancy Category C: There are no adequate and well-controlled studies in pregnant women; therefore, escitalopram should be used in pregnancy only if the potential benefit justifies the potential risks to the fetus.
Labor and Delivery: The effect of escitalopram on labor and delivery in humans is unknown.
Use in lactation: Escitalopram, like citalopram is excreted into human breast milk. Studies in breastfeeding mothers have shown that the mean combined dose of citalopram and demethylcitalopram transmitted to infants via breastmilk (expressed as a percentage of the weight-adjusted maternal dose) is 4.4 to 5.1%. Plasma concentrations of these drugs in infants were very low or absent and there were no adverse effects. While citalopram data support the safety of use of escitalopram in breastfeeding women the decision to breastfeed should always be made as an individual risk/benefit analysis.